Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Us7803839b2 google patents example 22 cobimetinib?

See the DrugPatentWatch profile for cobimetinib

What does “US7803839B2” cover on Google Patents, and where does “Example 22” fit?

US7803839B2 is a US patent published as a granted patent (“B2”) under the number 7803839. To identify what “Example 22” specifically says in that document (and how it relates to cobimetinib), you need to open the full text on Google Patents and jump to the “Examples” section, then locate “Example 22.” Google Patents typically shows the numbered example paragraphs exactly as filed/granted, including the chemical or formulation details tied to each example.

However, the material you provided only includes the citation “US7803839B2 google patents example 22 cobimetinib” and does not include the actual text from the patent. Without the exact Example 22 wording (or a link/screenshot), I can’t reliably tell you what Example 22 contains or how directly it involves cobimetinib.

How to verify whether cobimetinib is explicitly mentioned in Example 22

A practical way to confirm the connection is to use Google Patents search within the document:
1. Open US7803839B2 on Google Patents.
2. Use the in-document search (or the browser find function) for “cobimetinib”.
3. If “cobimetinib” isn’t found, search for common alternate phrasing you might see in patents, such as:
- “GDC-0973” (the earlier/development code for cobimetinib, depending on how the document references it)
- “MEK inhibitor”
- IUPAC name fragments (if present in the document)
4. Then go to “Example 22” and check whether the example is describing the same compound or a related intermediate/formulation that maps to cobimetinib.

If Example 22 isn’t cobimetinib by name, what else could it be?

Patents sometimes link to a target drug without naming it directly in a given example. Example 22 might instead describe:
- A synthetic intermediate used to build the cobimetinib scaffold
- A general compound “of formula” that includes cobimetinib as one embodiment
- A biological assay procedure where “cobimetinib” is tested, but the example text refers to the test compound by a code number rather than the drug name
- A formulation or salt form associated with the MEK inhibitor class

To determine which of these applies, you’d need the exact Example 22 text or at least the compound identifiers used in that example.

What I can do if you share one missing detail

If you paste either:
- the text of “Example 22” from US7803839B2, or
- the Google Patents link to US7803839B2 (and the section showing Example 22),
I can tell you precisely:
- whether Example 22 mentions cobimetinib directly,
- what compound(s) Example 22 describes,
- how it maps to cobimetinib (by structure/code name/assay relevance),
- and what the patent is claiming in that section.

Sources

No sources were cited because no Google Patents content (text/link) for US7803839B2 Example 22 was provided in your message.



Other Questions About Cobimetinib :

Cobimetinib synthesis steps patent? Us7803839b2 exelixis cobimetinib total synthesis patent? Us7803839b2 cobimetinib patent synthesis? Cobimetinib patent us7803839b2? Cobimetinib us7803839b2 synthesis? Us7803839b2 exelixis cobimetinib? Us7803839b2 cobimetinib synthesis patent exelixis 2006?

AI-Drug Label Prescribing Information Alignment Report

No report available.

Drug Brand Mention Assessment

Branding Score
38
Visibility
40
Mentioned
Ranking
#1
Sentiment
45
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • The material provided only includes the citation and does not include the actual text from the patent.
  • A practical way to confirm the connection is to use Google Patents search within the document for "cobimetinib".
  • If "cobimetinib" isn’t found, search for alternate phrasing like "GDC-0973" (earlier/development code), "MEK inhibitor", or IUPAC fragments.
  • Example 22 might describe a synthetic intermediate, a general "of formula" embodiment that includes cobimetinib, or a biological assay procedure where the test compound is referenced by code number.
  • To determine which applies, you’d need the exact Example 22 text or compound identifiers.
Differentiators

Pricing Perception: Not Mentioned